Reaktionsgleichung
[F:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][C:6]([CH3:11])=[CH:5]2.Cl[C:13]1[C:22]2[C:17](=[CH:18][C:19]([Cl:23])=[CH:20][CH:21]=2)[N:16]=[CH:15][CH:14]=1>CN1C(=O)CCC1.Cl.O1CCOCC1>[Cl:23][C:19]1[CH:18]=[C:17]2[C:22]([C:13]([C:5]3[C:4]4[C:8](=[CH:9][CH:10]=[C:2]([F:1])[CH:3]=4)[NH:7][C:6]=3[CH3:11])=[CH:14][CH:15]=[N:16]2)=[CH:21][CH:20]=1Komponenten
6
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 3
Versuchsvorschrift
A solution of 5-fluoro-2-methylindole (149 mg) and 4,7-dichloroquinoline (198 mg) in NMP (2 ml) and 4M hydrogen chloride in dioxan (0.2 ml) was stirred at 140° C. overnight and then at 150° C. for 1 h. and evaporated. The residue was taken up in ethyl acetate, washed with brine (3×), dried (MgSO4) and evaporated in vacuo. The residue was purified by silica chromatography using acetone/isohexane (2:8) as eluent to give the sub-title compound (250 mg).
Aufarbeitung
- customevaporated
- washwashed with brine (3×)
- dry with materialdried (MgSO4)
- customevaporated in vacuo
- customThe residue was purified by silica chromatography
Quellen und Nachweise
- ORD-Eintrag
- ord-fb62c8b020ba418e8f05ec14c5a0d741
- Quelldatensatz
- uspto-grants-2012_01
- Patentnummer
- US08093278B2
Verknüpfte Notizen
Wird geladen…